Charles Schwab’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Charles Schwab’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-888,450	Closed	-$16.6M	–	3718
2022 Q1	$16.6M	Buy	888,450 +69,803	+9%	+$1.26M	0.01%	1680
2021 Q4	$17.5M	Sell	818,647 -75,154	-8%	-$1.48M	0.01%	1686
2021 Q3	$16.5M	Buy	893,801 +271,220	+44%	+$5.46M	0.01%	1723
2021 Q2	$13.3M	Buy	622,581 +60,989	+11%	+$1.24M	﹤0.01%	1848
2021 Q1	$10.8M	Buy	+561,592	New	+$9.9M	﹤0.01%	1916

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Charles Schwab's OCDX Position: Q2 2022 in Review

Charles Schwab sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 888,450 shares — an estimated $16.6M sold.

Charles Schwab first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $17.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Charles Schwab reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Charles Schwab sold 888,450 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $16.6M.
Charles Schwab first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Charles Schwab's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $17.5M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.